Ultragenyx Pharmaceutical Inc has appointed Karah Parschauer as Executive Vice President, General Counsel. She will be responsible for leading the company’s legal, compliance, and corporate governance functions. Ms. Parschauer spent 11 years at Allergan plc, most recently as Vice President, Associate General Counsel. “I am pleased to welcome Karah to our leadership team as we advance our programs and come closer to bringing therapies to patients,” said Ultragenyx CEO Dr. Emil Kakkis. “Her industry experience will provide a valuable perspective to our team and will help facilitate Ultragenyx’s continued growth and success.”
For more information about this appointment, visit Ultragenyx’s website.